Andreopoulou E - Search Results

1

A pilot study of letrozole for one year in women at enhanced risk of developing breast cancer: effects on mammographic density.

Smith J, Dilawari A, Ursin G, Andreopoulou E, Checka C, Axelrod D, Guth A, Toth H, Utate M, Carapetyan K, Reich E, Diflo T, Muggia F. Smith J, et al. Among authors: andreopoulou e. Anticancer Res. 2012 Apr;32(4):1327-31. Anticancer Res. 2012. PMID: 22493366

2

An overview of the status of imaging screening technology for breast cancer.

Smith JA, Andreopoulou E. Smith JA, et al. Among authors: andreopoulou e. Ann Oncol. 2004;15 Suppl 1:I18-I26. doi: 10.1093/annonc/mdh653. Ann Oncol. 2004. PMID: 15280183 Review.

3

Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer.

Andreopoulou E, Gaiotti D, Kim E, Downey A, Mirchandani D, Hamilton A, Jacobs A, Curtin J, Muggia F. Andreopoulou E, et al. Ann Oncol. 2007 Apr;18(4):716-21. doi: 10.1093/annonc/mdl484. Epub 2007 Feb 13. Ann Oncol. 2007. PMID: 17301073 Free article.

4

Mucinous cancer of the appendix: challenges in diagnosis and treatment.

Andreopoulou E, Yee H, Warycha MA, Macari M, Berman R, Lowy A, Muggia F. Andreopoulou E, et al. J Chemother. 2007 Aug;19(4):451-4. doi: 10.1179/joc.2007.19.4.451. J Chemother. 2007. PMID: 17855191

5

Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer.

Andreopoulou E, Gaiotti D, Kim E, Volm M, Oratz R, Freedberg R, Downey A, Vogel CL, Chia S, Muggia F. Andreopoulou E, et al. Clin Breast Cancer. 2007 Aug;7(9):690-6. doi: 10.3816/CBC.2007.n.028. Clin Breast Cancer. 2007. PMID: 17919349 Clinical Trial.

6

Pharmacodynamics of tubulin and tubulin-binding agents: extending their potential beyond taxanes.

Andreopoulou E, Muggia F. Andreopoulou E, et al. Clin Breast Cancer. 2008 Mar;8 Suppl 2:S54-60. doi: 10.3816/cbc.2008.s.001. Clin Breast Cancer. 2008. PMID: 18637400 Review.

7

Weekly paclitaxel with intermittent imatinib mesylate (Gleevec): tolerance and activity in recurrent epithelial ovarian cancer.

Safra T, Andreopoulou E, Levinson B, Borgato L, Pothuri B, Blank S, Tiersten A, Boyd L, Curtin J, Muggia F. Safra T, et al. Among authors: andreopoulou e. Anticancer Res. 2010 Sep;30(9):3243-7. Anticancer Res. 2010. PMID: 20944093 Clinical Trial.

8

Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer.

Andreopoulou E, Chen T, Liebes L, Curtin J, Blank S, Wallach R, Hochster H, Muggia F. Andreopoulou E, et al. Cancer Chemother Pharmacol. 2011 Aug;68(2):457-63. doi: 10.1007/s00280-010-1510-y. Epub 2010 Nov 11. Cancer Chemother Pharmacol. 2011. PMID: 21069334 Clinical Trial.

9

Documentation of complete response in metastatic breast cancer to liver and bone achieved with trastuzumab and pegylated liposomal Doxorubicin.

Kobrinsky B, Andreopoulou E, Mourtzikos K, Muggia F. Kobrinsky B, et al. Among authors: andreopoulou e. Clin Med Oncol. 2008;2:469-70. doi: 10.4137/cmo.s482. Epub 2008 Jun 11. Clin Med Oncol. 2008. PMID: 21892319 Free PMC article. No abstract available.

10

Squamous cell carcinoma of the oral cavity in nonsmoking women: a new and unusual complication of chemotherapy for recurrent ovarian cancer?

Cannon TL, Lai DW, Hirsch D, Delacure M, Downey A, Kerr AR, Bannan M, Andreopoulou E, Safra T, Muggia F. Cannon TL, et al. Among authors: andreopoulou e. Oncologist. 2012;17(12):1541-6. doi: 10.1634/theoncologist.2011-0216. Epub 2012 May 23. Oncologist. 2012. PMID: 22622148 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters